Financhill
Back

Protagonist Therapeutics Stock Price Chart

Biden's Oil War: The Administration Is All-In on Green Energy.

Download Free Report
Sell
48

PTGX
Protagonist Therapeutics

Last Price:
28.49
Seasonality Move:
24.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Billionaire Investors Join Forces to Fund Next Generation

Learn More
  • The current trend is relatively stagnant and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Protagonist Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 28.36 Buy
20-day SMA: 29.6 Sell
50-day SMA: 27.81 Buy
200-day SMA: 21.75 Buy
8-day EMA: 28.46 Buy
20-day EMA: 28.79 Sell
50-day EMA: 27.5 Buy
200-day EMA: 22.71 Buy

Protagonist Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 48.84 Sell
Chaikin Money Flow: 211353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.26 - 30.76) Sell
Bollinger Bands (100): (19.04 - 28.62) Buy

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Protagonist Therapeutics Stock

Is Protagonist Therapeutics Stock a Buy?

PTGX Technical Analysis vs Fundamental Analysis

Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy or a Sell?

Protagonist Therapeutics Stock Info

Market Cap:
1.66B
Price in USD:
28.48
Share Volume:
359.3K

Protagonist Therapeutics 52-Week Range

52-Week High:
33.34
52-Week Low:
13.72
Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Protagonist Therapeutics Share Price Forecast

Is Protagonist Therapeutics Stock a Buy?

Fundamental Analysis of Protagonist Therapeutics

Is Protagonist Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.87 per share, and a decrease next year of $0.23 per share.

Technical Analysis of Protagonist Therapeutics

Should I short Protagonist Therapeutics stock?

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.